Trial intelligence / Profile preview

iPAPP trial of intravenous paracetamol for patent ductus arteriosus in preterm infants

jRCTs031220386Recruiting

Sponsor
AMED BIRTHDAY
Start
Oct 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of acetaminophen in patent ductus arteriosus (PDA) (2 arms), sponsored by AMED BIRTHDAY. Primary endpoint: Incidence of renal dysfunction. Started Oct 2022; status: recruiting.

02

Drugs

acetaminophen
03

Conditions

patent ductus arteriosus (PDA)

Beyond the preview

Go deeper on jRCTs031220386.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031220386.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call